Margins, models, and fragility: The fault lines of Australia’s private health sector

Australia’s healthcare system is a complex mix of public and private funding and service provision. While the private hospital sector is a critical component of the national healthcare system, its long-term sustainability is conditional and subject to a complex web of interconnected pressures.

The sector has faced mounting threats to its financial viability, caught in what has been described as the “jaws of death,” where operational costs rise faster than revenue, and workforce shortages and evolving models of care further intensify the challenge.

Highly publicised events, such as the liquidity issues facing Healthscope, have brought these vulnerabilities into sharp focus, raising significant questions regarding the sector’s long-term sustainability. The ongoing debate about a system characterised by differentiated access and waiting times based on insurance status also raises profound ethical and reputational questions for private providers.

A recent systematic review led by researchers at the University of Sydney examined 23 studies conducted over the past two decades, revealing a private health system marked by contradictions.

Ownership models, particularly the growth of private equity (PE) investment, have emerged as critical to understanding the sector’s vulnerability. Reliable data on PE shareholdings and their impact on clinical quality and organisational performance are scarce, making it difficult to assess long-term financial strategies and risks. PE structures often involve high debt-to-equity ratios and shorter-term investment horizons, amplifying financial fragility.

For-profit hospitals that rely on high-margin elective procedures are found to be particularly exposed to external shocks. Elective surgery shutdowns during the COVID-19 pandemic caused significant declines in revenue, revealing the fragility of business models concentrated on discretionary services, a model often favoured by corporate and PE owners.

The interplay between health policy reforms and private health insurance (PHI) incentives also shapes private hospital sector financial viability. The review emphasised the need for structural reforms to address fragmentation in funding and improve risk adjustment to meet the preconditions for an efficient mixed system. Conceptual frameworks for integrating public and private insurance under a “managed competition” model have been proposed to navigate this complexity.

Adjusting PHI incentives can generate government savings, but often at the expense of lower insurance coverage, shrinking the pool of patients whose revenue supports private hospitals. While rising PHI enrolment slightly reduces public hospital waiting times, its cost-effectiveness as a policy lever remains questionable.

The system also creates a substitution effect. Privately insured patients shift from public to private hospitals, though many continue to use public hospitals for complex care. This demonstrates that while PHI underpins private hospital demand, it does not completely insulate the public system, meaning private hospital viability is tied to patient flows determined by clinical need and perceived value, not just insurance status.

Consumer behaviour further influences financial pressures. The decision to purchase PHI is linked to health consciousness and trust in insurers, yet many young people lack confidence in its value. This trend threatens the community-rated insurance pool, potentially leading to higher premiums and a shrinking market, reducing the customer base for private hospitals.

Even among insured patients, hospital choice is complex. Many continue to use public hospitals due to cost considerations or the need for complex care. Public performance reporting has minimal influence on patient choice, with most relying on specialist recommendations. Private emergency services are limited, restricting access.

The Road Ahead

A key implication of this review is that current policy levers, particularly PHI incentives, are inadequate to tackle the sector’s core challenges of viability and equity. Evidence indicates that simply encouraging PHI uptake does little to meaningfully reduce public hospital waiting lists. Policies that rely on PHI as the primary tool for managing public system demand risk being an inefficient use of public funds when viewed from a whole-of-system perspective.

What is required instead is a sophisticated, structural approach, one that moves beyond blunt incentives and addresses fundamental issues such as fee transparency, value-based payment models, and sustainable service mix.

Proposals for the Independent Hospital Pricing Authority to set a Private National Efficient Price (PNEP) for private hospital services have been debated, offering a potential mechanism to curb excessive costs and improve accountability. Yet these face significant resistance from patients whose care would be impacted and from stakeholders whose business models would be fundamentally altered, echoing the contested reforms of the 1990s, such as the Private Hospital Bed Day Subsidy.

The authors conclude that any effective policy framework must be both economically rigorous and politically feasible, such as the models envisaged under “managed competition”. Without structural reform, the private hospital sector risks remaining trapped in a cycle of financial vulnerability, inequitable access, and strategic uncertainty.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.